Navigation Links
Innovations in Patient-Focused Initiatives to Improve Outcomes
Date:2/10/2011

CHAPEL HILL, N.C., Feb. 10, 2011 /PRNewswire/ -- For the biopharmaceutical industry, the changing healthcare marketplace has increased the importance - and difficulty - of interacting with patients to improve outcomes. New technologies and access restrictions have created both opportunities and challenges for approaching and engaging patient populations to improve disease control.

To help marketing teams in the biopharmaceutical industry connect more effectively with patient groups, Best Practices, LLC has published a new report, "Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging and Supporting Patients." This 62-page report examines innovative biopharmaceutical programs and initiatives aimed at directly affecting the lives and treatment of patients.

While leaders of patient-focused initiatives recognize the close relationship between patient involvement and health outcomes, patients' increased access to information does not on its own guarantee better outcomes. There is little to no increase in a program's effectiveness if the content of the information being provided to patients is not an improvement on the information already available through conventional methods.

Innovation in patient messaging seems to thrive in special circumstances, such as orphan conditions and chronic diseases where uptake can mean a long-term relationship, according to the study. The study includes a mix of quantitative data and numerous examples of different patient engagement approaches used by pharma groups. Key study objectives included:

  • Gaining insights into the current landscape and the future of these patient-focused initiatives
  • Collect examples and develop "case studies" of innovative programs and initiatives
  • Describe the rationale and objectives of these efforts
  • Define the conditions and measures of success
  • Understand the potential pitfalls and limitations of such efforts
  • Gain insights into the future of these patient-focused initiatives

To download a complimentary excerpt of this report, go to: http://www3.best-in-class.com/rr1041.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 45 marketing leaders at 34 different companies participated in the research project. Two-thirds were in pharma and the remainder were in either biotech or medical devices. Twelve of the Top 20 pharma companies participated.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DSM Recognized With Profiles in Sustainability Award for Corporate Commitment to Sustainability and Innovations for Pharmaceutical Manufacturing
2. Young Innovations, Inc. Provides 4th Quarter Conference Call Details
3. Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
4. RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group
5. Omnicell to Showcase Latest Product Innovations at ASHP
6. Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010
7. Innovations in Injectables: Current and emerging technologies to improve drug delivery
8. Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates
9. Cleveland Clinic Unveils Top 10 Medical Innovations for 2011
10. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend
11. Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches by the U.S. FDA Commissioner, U.S. CMS Administrator, CBS Evening News Anc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
(Date:6/30/2017)... June 30, 2017  AVACEN Medical (AVACEN) announced the publication of ... describes the use of its AVACEN Treatment Method to ... fibromyalgia. ... AVACEN Medical ... chronic widespread pain. It affects approximately 200 to 400 million people worldwide ...
Breaking Medicine Technology:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... Bernard R. ... Past President of the American Orthopaedic Society of Sports Medicine (AOSSM) , received ... during the AOSSM Annual Meeting in Toronto, Canada. This prestigious award is given annually ...
(Date:7/21/2017)... , ... July 21, 2017 , ... “Kids aren't born ... to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company ... which launches on Kickstarter on Monday, July 21st. , The kit uses colorful, ...
(Date:7/21/2017)... ... July 21, 2017 , ... How ... are on the rise, say researchers presenting their work at the American ... , “The combination of evaluating the patterns of change in concussion symptom presentation, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats Rose, ... pleased to announce their expansion to the Midwest with the establishment of the ... and Ronald Bell, and of counsels, John Peck and Robert Bruns, will establish ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar ... non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it has ... to complete regulatory submissions and fund final engineering and initial production of the ...
Breaking Medicine News(10 mins):